Prince Pharmaceutical Co., Ltd.

NT$26.85As of Sun 8 Nov 2026, 12:00 UTC
TPEx:6935Healthcare
Country Taiwan
PE (Fwd) •••
TSR 4Y CAGR (18.79%)
Div yield 1.86%
ROE 16.14%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.59
PE TTM 7.708
TSR TTM (11.49%)
Mkt cap NT$1.004B
ROIC 12.72%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$34
25.48%
50.06%
Hold 5|1|6|9|1
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.25
0.24
0.25
0.26
9.68%
(1.16%)
(2.29%)
0.92%
RevenueNT$M
74.58
72.95
73.87
74.08
11.24%
4.29%
2.07%
3.51%
Peers (US$30.28M)
Cap (US$)
PE
32.68M
—
Capital
TTM
5Y
10Y
Leveragex
0.586
(0.079)
(0.069)
EBIT/Intx
0.753
0.439
0.382
Own earn%
110.21
362.67
344.66
Sh yield%
26.11
39.24
39.81
Owners
Insiders/Inst%
4.73
37.95
Short interest%
2.02
SBC / revenue%
4.31
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
35–48
$1 testx
0.5
Incr. ROIC%
3